Amyloidosis: open trials in Netherlands

16 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Universitair Medisch Centrum Groningen, Groningen · Academisch Ziekenhuis Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-04
NCT05652335
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Amsterdam UMC, Amsterdam · METC Universitair Medisch Centrum Groningen, Groningen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Groningen · Maastricht · Utrecht
Registry updated 2026-10-21
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Trial Treatment · Phase 3 · Novo Nordisk A/S
University Medical Center Groningen, Groningen · Maastricht University Medical Center+ (MUMC+), Maastricht · Erasmus Medisch Centrum 1, Rotterdam · Universitair Medisch Centrum Utrecht (Umc Utrecht), Utrecht
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Catharina Ziekenhuis Stichting, Eindhoven · Universitair Medisch Centrum Groningen, Groningen · Academisch Ziekenhuis Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-20
NCT04561518
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Research · Alnylam Pharmaceuticals
Groningen
Registry updated 2026-10-13
NCT05040373
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Research · Alnylam Pharmaceuticals
Groningen
Registry updated 2026-10-08
NCT06768489
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-09-25
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-18
NCT07116473
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Universitair Medisch Centrum Groningen, Groningen · Academisch Ziekenhuis Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-11
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Universitair Medisch Centrum Groningen, Groningen · Academisch Ziekenhuis Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-04
NCT05776212
Quantitative-imaging in Cardiac Transthyretin Amyloidosis
Research · University of Edinburgh
University Medical Centre Groningen, Groningen
Registry updated 2026-06-26
NCT06205953
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Research · Fondazione IRCCS Policlinico San Matteo di Pavia
UMC Utrecht, dept Hematology, Amyloid Expertise Center, Utrecht, Heidelberglaan, Utrecht
Registry updated 2026-04-16
NCT07448623
A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.
Trial Treatment · Phase 1 · Novo Nordisk A/S
Pharmaceutical Research Associates Group B.V., Groningen
Registry updated 2026-04-13
NCT06894290
International Cardiac Amyloidosis Registry
Research · Leiden University Medical Center
Leiden University Medical Center, Leiden
Registry updated 2025-03-25
NCT06836011
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
Research · Medical University of Vienna
University Medical Center Utrecht, Utrecht
Registry updated 2025-02-19

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error